No Data
Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript Summary
Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript
Addex Therapeutics Reports Substantial Asset Growth
Earnings Scheduled For November 22, 2024
Addex Therapeutics Reported Q3 EPS Of CHF(0.02) Up From CHF(0.03), Cash Balance Of CHF3.35M
addex therapeutics (ADXN.US) will release earnings report before market open on November 22nd.
$Addex Therapeutics(ADXN.US)$ will release its financial report before the market opens on November 22. How was its previous performance? $Addex Therapeutics(ADXN.US)$ had a revenue of 0.115277 million francs, net income of 12.878632 million francs, and earnings per share of 9.6 francs in 2024/Q2. In 2023/Q3, the revenue was 0.327733 million francs, net income was -2.61707 million francs, and earnings per share was -3.6 francs. futubull reminder: 1. Hong Kong and U.S. stocks
No Data